U.S. stock indexes are wavering following a strong profit report from Google’s parent company, while drops for Eli Lilly and ...

Asian shares are mostly declining amid uncertainty ahead of the United States presidential election next week.

Mitch Daniels, former governor of Indiana and president emeritus of Purdue University, will speak at 7 p.m. Feb. 17 at Tilson Auditorium, Indiana State University. The event is part of the school’s ...

Q3 sales in weight loss drugs Mounjaro and Zepbound were more than 20% lower than consensus analyst forecasts, spooking investors.

Over the last month, Dell and Super Micro have been sparring in the headlines with new product releases. Just two weeks ago, ...

The S&P 500 slipped 0.3 percent after drifting between small gains and losses several times, though it's still near its ...

Eli Lilly ( LLY) is planning to advertise its blockbuster weight loss drug, Zepbound, for the first time next month. Despite investor and industry recognition of the branded GLP-1 drug, "unaided ...

Eli Lilly’s stock heads for biggest selloff in more than three years after sales of anti-obesity drugs Mounjaro and Zepbound ...

For adolescents, weight loss after bariatric surgery was durable out to 10 years, data from the Teen Longitudinal Assessment ...

Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase ...

Eli Lilly's blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro posted weaker-than-expected sales for the ...